Home › US companies › Astrazeneca
Astrazeneca
AZN · NYSE · Pharmaceutical Preparations
Insider buys (12 months)
$3,249
Insider sales (12 months)
$2.2M
8-K reports (12 months)
0
Tracked investors holding
2
At a glance
In the last 12 months 1 insider reported 1 open-market purchase ($3,249) and 1 sale ($2.2M). None of the sales were flagged as 10b5-1 plan trades. The largest was a sale of $2.2M by See Remarks Mani Sharma on May 22, 2026. Net, insiders were sellers of $2.2M.
2 of the 20 investors tracked here held Astrazeneca at the last quarter end, worth $17.2M combined. It is the largest weight for Renaissance Technologies (0% of its portfolio), followed by Bridgewater Associates (0%). New this quarter: Renaissance Technologies and Bridgewater Associates.
Tracked investors holding (13F)
Renaissance TechnologiesNew$15.9M · 0.0% · held 4 quarters
Bridgewater AssociatesNew$1.3M · 0.0% · held 5 quarters
Weight is the share of each investor's portfolio, as of the quarter end.
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined